name,category,termsATP-binding cassette, sub-family C (CFTR/MRP), member 10,COG_ONTOLOGY[90000055$Defense mechanisms]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,INTERPRO[450001001$IPR001140:ABC transporter, transmembrane region, 450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450016190$IPR017871:ABC transporter, conserved site, 450016252$IPR017940:ABC transporter integral membrane type 1]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,KEGG_PATHWAY[470038812$hsa02010:ABC transporters]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,PIR_SUPERFAMILY[630002866$PIRSF002775:human multidrug resistance protein cMOAT2]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,UP_SEQ_FEATURE[850032752$chain:Multidrug resistance-associated protein 7, 850102992$domain:ABC transmembrane type-1 1, 850102993$domain:ABC transmembrane type-1 2, 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850106258$modified residue, 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
DNA-damage-inducible transcript 3,BIOCARTA[30000215$h_p38mapkPathway:p38 MAPK Signaling Pathway ]
DNA-damage-inducible transcript 3,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper, 450014991$IPR016670:DNA damage-inducible transcript 3]
DNA-damage-inducible transcript 3,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
DNA-damage-inducible transcript 3,OMIM_DISEASE[520003538$Myxoid liposarcoma]
DNA-damage-inducible transcript 3,PIR_SUPERFAMILY[630013356$PIRSF016571:C/EBPzeta_CHOP_DDIT3]
DNA-damage-inducible transcript 3,SMART[760000306$SM00338:BRLZ]
DNA-damage-inducible transcript 3,SP_PIR_KEYWORDS[790000258$cell cycle, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000466$dna-binding, 790000631$growth arrest, 790001065$nucleus, 790001212$polymorphism, 790001271$Proto-oncogene, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
DNA-damage-inducible transcript 3,UP_SEQ_FEATURE[850015529$chain:DNA damage-inducible transcript 3, 850102572$compositionally biased region:Poly-Glu, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850117295$sequence variant]
HLA complex P5,OMIM_DISEASE[520002032$Genome-wide association study targeting hIV1 viral setpoint., 520002068$Genomewide Association Study of an AIDS-Nonprogression Cohort Emphasizes the Role Played by HLA Genes (ANRS Genomewide Association Study 02).]
HLA complex P5,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
HLA complex P5,UP_SEQ_FEATURE[850024214$chain:HLA class I histocompatibility antigen protein P5, 850117294$sequence conflict, 850117295$sequence variant]
MLX interacting protein-like,BIOCARTA[30000063$h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP]
MLX interacting protein-like,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
MLX interacting protein-like,OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520002062$Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
MLX interacting protein-like,SMART[760000321$SM00353:HLH]
MLX interacting protein-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001640$williams-beuren syndrome]
MLX interacting protein-like,UP_SEQ_FEATURE[850100885$chain:Williams-Beuren syndrome chromosomal region 14 protein, 850102580$compositionally biased region:Poly-Pro, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
PDZ and LIM domain 2 (mystique),INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450001575$IPR001781:Zinc finger, LIM-type]
PDZ and LIM domain 2 (mystique),PIR_SUPERFAMILY[630014741$PIRSF018094:PDZ and LIM domain protein]
PDZ and LIM domain 2 (mystique),SMART[760000114$SM00132:LIM, 760000200$SM00228:PDZ]
PDZ and LIM domain 2 (mystique),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000864$LIM domain, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001648$zinc]
PDZ and LIM domain 2 (mystique),UP_SEQ_FEATURE[850036978$chain:PDZ and LIM domain protein 2, 850102597$compositionally biased region:Ser-rich, 850104716$domain:LIM zinc-binding, 850104918$domain:PDZ, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
TGFB-induced factor homeobox 2,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
TGFB-induced factor homeobox 2,SMART[760000341$SM00389:HOX]
TGFB-induced factor homeobox 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
TGFB-induced factor homeobox 2,UP_SEQ_FEATURE[850024671$chain:Homeobox protein TGIF2, 850102935$DNA-binding region:Homeobox; TALE-type, 850106258$modified residue, 850106259$mutagenesis site, 850114222$region of interest:Repressive function]
TRAF interacting protein,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
TRAF interacting protein,SMART[760000158$SM00184:RING]
TRAF interacting protein,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001162$phosphoprotein, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
TRAF interacting protein,UP_SEQ_FEATURE[850064869$chain:TRAF-interacting protein, 850106258$modified residue, 850112240$region of interest:Interaction with CYLD, 850117294$sequence conflict, 850118911$zinc finger region:RING-type]
acyl-Coenzyme A oxidase 1, palmitoyl,BIOCARTA[30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)]
acyl-Coenzyme A oxidase 1, palmitoyl,INTERPRO[450001257$IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site, 450002355$IPR002655:Acyl-CoA oxidase, C-terminal, 450005525$IPR006091:Acyl-CoA oxidase/dehydrogenase, central region, 450010980$IPR012258:Acyl-CoA oxidase, 450012383$IPR013764:Acyl-CoA oxidase/dehydrogenase, type1/2, C-terminal, 450012398$IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal]
acyl-Coenzyme A oxidase 1, palmitoyl,KEGG_PATHWAY[470038734$hsa00071:Fatty acid metabolism, 470038782$hsa00592:alpha-Linolenic acid metabolism, 470038811$hsa01040:Biosynthesis of unsaturated fatty acids, 470038821$hsa03320:PPAR signaling pathway]
acyl-Coenzyme A oxidase 1, palmitoyl,OMIM_DISEASE[520003961$Peroxisomal acyl-CoA oxidase deficiency]
acyl-Coenzyme A oxidase 1, palmitoyl,PIR_SUPERFAMILY[630000202$PIRSF000168:acyl-CoA oxidase, 630000203$PIRSF000168:Acyl-CoA_oxidase]
acyl-Coenzyme A oxidase 1, palmitoyl,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000537$FAD, 790000541$fatty acid beta-oxidation, 790000543$fatty acid metabolism, 790000559$Flavoprotein, 790000873$lipid metabolism, 790001092$oxidoreductase, 790001128$peroxisome, 790001162$phosphoprotein, 790001212$polymorphism]
acyl-Coenzyme A oxidase 1, palmitoyl,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000341$binding site:FAD, 850000343$binding site:FAD; via amide nitrogen, 850037915$chain:Peroxisomal acyl-coenzyme A oxidase 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117578$short sequence motif:Microbody targeting signal, 850118574$splice variant]
clathrin, light chain (Lcb),INTERPRO[450000867$IPR000996:Clathrin light chain]
clathrin, light chain (Lcb),KEGG_PATHWAY[470038840$hsa04142:Lysosome, 470038841$hsa04144:Endocytosis, 470038894$hsa05016:Huntington's disease]
clathrin, light chain (Lcb),PIR_SUPERFAMILY[630002413$PIRSF002289:clathrin light chain]
clathrin, light chain (Lcb),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000334$coated pit, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000447$disulfide bond, 790000919$membrane, 790001162$phosphoprotein]
clathrin, light chain (Lcb),UP_SEQ_FEATURE[850011634$chain:Clathrin light chain B, 850102883$disulfide bond, 850106258$modified residue, 850113150$region of interest:Involved in binding clathrin heavy chain, 850117294$sequence conflict, 850118574$splice variant]
eukaryotic translation initiation factor 2-alpha kinase 2,BIOCARTA[30000094$h_eif2Pathway:Regulation of eIF2, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000250$h_ranklPathway:Bone Remodelling, 30000262$h_rnaPathway:Double Stranded RNA Induced Gene Expression, 30000300$h_tollPathway:Toll-Like Receptor Pathway]
eukaryotic translation initiation factor 2-alpha kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001016$IPR001159:Double-stranded RNA binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450013172$IPR014720:Double-stranded RNA-binding-like, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
eukaryotic translation initiation factor 2-alpha kinase 2,SMART[760000326$SM00358:DSRM]
eukaryotic translation initiation factor 2-alpha kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000104$Antiviral defense, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001388$serine/threonine-protein kinase, 790001547$transferase]
eukaryotic translation initiation factor 2-alpha kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850026469$chain:Interferon-induced, double-stranded RNA- activated protein kinase, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850109967$region of interest:2 X 13 AA approximate repeats, 850115074$repeat:1, 850115273$repeat:2, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
folliculin interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
folliculin interacting protein 1,UP_SEQ_FEATURE[850019802$chain:Folliculin-interacting protein 1, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
glioblastoma amplified sequence,INTERPRO[450011257$IPR012577:NIPSNAP]
glioblastoma amplified sequence,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome]
glioblastoma amplified sequence,UP_SEQ_FEATURE[850047036$chain:Protein NipSnap homolog 2, 850106258$modified residue, 850117294$sequence conflict]
heart and neural crest derivatives expressed 1,BIOCARTA[30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart)]
heart and neural crest derivatives expressed 1,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
heart and neural crest derivatives expressed 1,SMART[760000321$SM00353:HLH]
heart and neural crest derivatives expressed 1,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
heart and neural crest derivatives expressed 1,UP_SEQ_FEATURE[850023020$chain:Heart- and neural crest derivatives- expressed protein 1, 850102565$compositionally biased region:Poly-Ala, 850102574$compositionally biased region:Poly-His, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850106258$modified residue]
hect domain and RLD 5,COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton]
hect domain and RLD 5,INTERPRO[450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450000485$IPR000569:HECT, 450008218$IPR009091:Regulator of chromosome condensation/beta-lactamase-inhibitor protein II]
hect domain and RLD 5,PIR_SUPERFAMILY[630029192$PIRSF037625:HERC protein]
hect domain and RLD 5,SMART[760000104$SM00119:HECTc]
hect domain and RLD 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
hect domain and RLD 5,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850041856$chain:Probable E3 ubiquitin-protein ligase HERC5, 850104105$domain:HECT, 850116898$repeat:RCC1 1, 850116909$repeat:RCC1 2, 850116910$repeat:RCC1 3, 850116911$repeat:RCC1 4, 850116912$repeat:RCC1 5, 850117295$sequence variant]
hypothetical LOC100128770,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
hypothetical LOC100128770,UP_SEQ_FEATURE[850055425$chain:Putative uncharacterized protein FLJ46214, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
kinesin family member 2B,INTERPRO[450001552$IPR001752:Kinesin, motor region, 450018052$IPR019821:Kinesin, motor region, conserved site]
kinesin family member 2B,PIR_SUPERFAMILY[630002446$PIRSF002323:kinesin-related protein KIF2]
kinesin family member 2B,SMART[760000111$SM00129:KISc]
kinesin family member 2B,SP_PIR_KEYWORDS[790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000827$kinetochore, 790000960$microtubule, 790000973$mitosis, 790000986$motor protein, 790001063$nucleotide-binding, 790001212$polymorphism]
kinesin family member 2B,UP_SEQ_FEATURE[850027492$chain:Kinesin-like protein KIF2B, 850104543$domain:Kinesin-motor, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
late cornified envelope 4A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 4A,UP_SEQ_FEATURE[850028035$chain:Late cornified envelope protein 4A, 850102480$compositionally biased region:Cys-rich, 850117295$sequence variant]
major histocompatibility complex, class I, A,BBID[10000091$70.Signal_peptides_(MHC)_class_I_molecules]
major histocompatibility complex, class I, A,BIOCARTA[30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000187$h_mhcPathway:Antigen Processing and Presentation, 30000202$h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity]
major histocompatibility complex, class I, A,INTERPRO[450000912$IPR001039:MHC class I, alpha chain, alpha1 and alpha2, 450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003158$IPR003597:Immunoglobulin C1-set, 450006486$IPR007110:Immunoglobulin-like, 450009629$IPR010579:MHC class I, alpha chain, C-terminal, 450010088$IPR011161:MHC class I-like antigen recognition, 450012396$IPR013783:Immunoglobulin-like fold]
major histocompatibility complex, class I, A,KEGG_PATHWAY[470038841$hsa04144:Endocytosis, 470038855$hsa04514:Cell adhesion molecules (CAMs), 470038860$hsa04612:Antigen processing and presentation, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038888$hsa04940:Type I diabetes mellitus, 470038915$hsa05320:Autoimmune thyroid disease, 470038917$hsa05330:Allograft rejection, 470038918$hsa05332:Graft-versus-host disease, 470038923$hsa05416:Viral myocarditis]
major histocompatibility complex, class I, A,OMIM_DISEASE[520000086$Abacavir hypersensitivity, susceptibility to, 520000336$Ankylosing spondylitis, susceptibility to, 1, 520004694$Stevens-Johnson syndrome, susceptibility to]
major histocompatibility complex, class I, A,PIR_SUPERFAMILY[630002127$PIRSF001990:class I histocompatibility antigen]
major histocompatibility complex, class I, A,SMART[760000355$SM00407:IGc1]
major histocompatibility complex, class I, A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000679$heterodimer, 790000733$host-virus interaction, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790000924$membrane protein, 790000955$mhc i, 790000956$mhc ii, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001461$sulfation, 790001555$transmembrane, 790001556$transmembrane protein, 790001557$transplantation antigen, 790001592$ubl conjugation]
major histocompatibility complex, class I, A,UP_SEQ_FEATURE[850024215$chain:HLA class I histocompatibility antigen, A-1 alpha chain, 850024216$chain:HLA class I histocompatibility antigen, A-11 alpha chain, 850024217$chain:HLA class I histocompatibility antigen, A-2 alpha chain, 850024218$chain:HLA class I histocompatibility antigen, A-23 alpha chain, 850024219$chain:HLA class I histocompatibility antigen, A-24 alpha chain, 850024220$chain:HLA class I histocompatibility antigen, A-25 alpha chain, 850024221$chain:HLA class I histocompatibility antigen, A-26 alpha chain, 850024222$chain:HLA class I histocompatibility antigen, A-29 alpha chain, 850024223$chain:HLA class I histocompatibility antigen, A-3 alpha chain, 850024224$chain:HLA class I histocompatibility antigen, A-31 alpha chain, 850024225$chain:HLA class I histocompatibility antigen, A-32 alpha chain, 850024226$chain:HLA class I histocompatibility antigen, A-34 alpha chain, 850024227$chain:HLA class I histocompatibility antigen, A-36 alpha chain, 850024228$chain:HLA class I histocompatibility antigen, A-43 alpha chain, 850024229$chain:HLA class I histocompatibility antigen, A-66 alpha chain, 850024230$chain:HLA class I histocompatibility antigen, A-68 alpha chain, 850024231$chain:HLA class I histocompatibility antigen, A-69 alpha chain, 850024232$chain:HLA class I histocompatibility antigen, A-80 alpha chain, 850031600$chain:MHC class I antigen, 850102883$disulfide bond, 850104352$domain:Ig-like C1-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850110907$region of interest:Alpha-1, 850110908$region of interest:Alpha-2, 850110909$region of interest:Alpha-3, 850111296$region of interest:Connecting peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
myosin regulatory light chain interacting protein,INTERPRO[450000257$IPR000299:FERM domain, 450000692$IPR000798:Ezrin/radixin/moesin ERM, 450001628$IPR001841:Zinc finger, RING-type, 450010818$IPR011993:Pleckstrin homology-type, 450012944$IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type, 450017249$IPR018979:FERM, N-terminal, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain, 450017987$IPR019750:Band 4.1 subgroup]
myosin regulatory light chain interacting protein,SMART[760000158$SM00184:RING, 760000266$SM00295:B41]
myosin regulatory light chain interacting protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790000937$metal-binding, 790001212$polymorphism, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
myosin regulatory light chain interacting protein,UP_SEQ_FEATURE[850016681$chain:E3 ubiquitin-protein ligase MYLIP, 850103760$domain:FERM, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118911$zinc finger region:RING-type]
neighbor of BRCA1 gene 1,INTERPRO[450000235$IPR000270:Octicosapeptide/Phox/Bem1p, 450000371$IPR000433:Zinc finger, ZZ-type, 450000382$IPR000449:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, 450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote]
neighbor of BRCA1 gene 1,SMART[760000144$SM00165:UBA, 760000262$SM00291:ZnF_ZZ, 760000579$SM00666:PB1]
neighbor of BRCA1 gene 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
neighbor of BRCA1 gene 1,UP_SEQ_FEATURE[850034176$chain:Next to BRCA1 gene 1 protein, 850102572$compositionally biased region:Poly-Glu, 850104868$domain:OPR, 850105597$domain:UBA, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118951$zinc finger region:ZZ-type]
phosphatidylinositol transfer protein, alpha,INTERPRO[450001476$IPR001666:Phosphatidylinositol transfer protein]
phosphatidylinositol transfer protein, alpha,PIR_SUPERFAMILY[630012280$PIRSF015478:phosphatidylinositol transfer protein]
phosphatidylinositol transfer protein, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000876$lipid-binding, 790001155$phospholipid binding, 790001159$phospholipid transport, 790001162$phosphoprotein, 790001558$transport]
phosphatidylinositol transfer protein, alpha,UP_SEQ_FEATURE[850038435$chain:Phosphatidylinositol transfer protein alpha isoform, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
pleiomorphic adenoma gene-like 2; similar to pleiomorphic adenoma gene-like 2,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
pleiomorphic adenoma gene-like 2; similar to pleiomorphic adenoma gene-like 2,SMART[760000323$SM00355:ZnF_C2H2]
pleiomorphic adenoma gene-like 2; similar to pleiomorphic adenoma gene-like 2,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
pleiomorphic adenoma gene-like 2; similar to pleiomorphic adenoma gene-like 2,UP_SEQ_FEATURE[850102052$chain:Zinc finger protein PLAGL2, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
polymerase (RNA) III (DNA directed) polypeptide C (62kD),INTERPRO[450008053$IPR008806:RNA polymerase III Rpc82, C -terminal, 450011834$IPR013197:RNA polymerase III subunit RPC82-related, helix-turn-helix]
polymerase (RNA) III (DNA directed) polypeptide C (62kD),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism, 470038815$hsa03020:RNA polymerase, 470038865$hsa04623:Cytosolic DNA-sensing pathway]
polymerase (RNA) III (DNA directed) polypeptide C (62kD),SP_PIR_KEYWORDS[790000104$Antiviral defense, 790000356$complete proteome, 790000468$dna-directed rna polymerase, 790000763$immune response, 790000777$innate immunity, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription]
polymerase (RNA) III (DNA directed) polypeptide C (62kD),UP_SEQ_FEATURE[850016061$chain:DNA-directed RNA polymerase III subunit RPC3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
similar to ubiquitin associated and SH3 domain containing, A; ubiquitin associated and SH3 domain containing, A,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
similar to ubiquitin associated and SH3 domain containing, A; ubiquitin associated and SH3 domain containing, A,INTERPRO[450000382$IPR000449:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, 450001294$IPR001452:Src homology-3 domain, 450011723$IPR013078:Phosphoglycerate mutase, 450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote]
similar to ubiquitin associated and SH3 domain containing, A; ubiquitin associated and SH3 domain containing, A,OMIM_DISEASE[520001922$Follow up analysis of genome-wide association data identifies novel loci for type 1 diabetes]
similar to ubiquitin associated and SH3 domain containing, A; ubiquitin associated and SH3 domain containing, A,SMART[760000144$SM00165:UBA, 760000295$SM00326:SH3]
similar to ubiquitin associated and SH3 domain containing, A; ubiquitin associated and SH3 domain containing, A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001212$polymorphism, 790001398$sh3 domain]
similar to ubiquitin associated and SH3 domain containing, A; ubiquitin associated and SH3 domain containing, A,UP_SEQ_FEATURE[850068052$chain:Ubiquitin-associated and SH3 domain- containing protein A, 850105350$domain:SH3, 850105597$domain:UBA, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),INTERPRO[450006867$IPR007513:Four F5 protein]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),UP_SEQ_FEATURE[850060991$chain:Small EDRK-rich factor 1, 850118574$splice variant]
solute carrier family 13 (sodium/sulfate symporters), member 4,COG_ONTOLOGY[90000075$Inorganic ion transport and metabolism]
solute carrier family 13 (sodium/sulfate symporters), member 4,INTERPRO[450001680$IPR001898:Sodium/sulphate symporter]
solute carrier family 13 (sodium/sulfate symporters), member 4,PIR_SUPERFAMILY[630005758$PIRSF005833:sodium/sulfate cotransporter]
solute carrier family 13 (sodium/sulfate symporters), member 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001473$Symport, 790001555$transmembrane, 790001558$transport]
solute carrier family 13 (sodium/sulfate symporters), member 4,UP_SEQ_FEATURE[850061364$chain:Solute carrier family 13 member 4, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 22 (organic anion/urate transporter), member 12,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 22 (organic anion/urate transporter), member 12,OMIM_DISEASE[520002574$Hypouricemia, renal]
solute carrier family 22 (organic anion/urate transporter), member 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier family 22 (organic anion/urate transporter), member 12,UP_SEQ_FEATURE[850061388$chain:Solute carrier family 22 member 12, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
tenascin XB; tenascin XA pseudogene,INTERPRO[450000637$IPR000742:EGF-like, type 3, 450001934$IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, 450003484$IPR003961:Fibronectin, type III, 450005636$IPR006210:EGF-like, 450008173$IPR008957:Fibronectin, type III-like fold, 450011699$IPR013032:EGF-like region, conserved site, 450011755$IPR013111:EGF, extracellular, 450013168$IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1]
tenascin XB; tenascin XA pseudogene,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
tenascin XB; tenascin XA pseudogene,OMIM_DISEASE[520001651$Ehlers-Danlos due to tenascin X deficiency, 520001654$Ehlers-Danlos syndrome, hypermobility type]
tenascin XB; tenascin XA pseudogene,PIR_SUPERFAMILY[630002620$PIRSF002500:tenascin-X]
tenascin XB; tenascin XA pseudogene,SMART[760000051$SM00060:FN3, 760000155$SM00181:EGF, 760000160$SM00186:FBG]
tenascin XB; tenascin XA pseudogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000481$egf-like domain, 790000487$Ehlers-Danlos syndrome, 790000530$extracellular matrix, 790000616$glycoprotein, 790001162$phosphoprotein, 790001212$polymorphism, 790001272$pseudogene, 790001304$repeat, 790001363$Secreted, 790001405$signal]
tenascin XB; tenascin XA pseudogene,UP_SEQ_FEATURE[850054733$chain:Putative tenascin-XA, 850063823$chain:Tenascin-X, 850102883$disulfide bond, 850103598$domain:EGF-like 10, 850103601$domain:EGF-like 11, 850103603$domain:EGF-like 12, 850103605$domain:EGF-like 13, 850103607$domain:EGF-like 14, 850103609$domain:EGF-like 15, 850103611$domain:EGF-like 16, 850103613$domain:EGF-like 17, 850103615$domain:EGF-like 18, 850103617$domain:EGF-like 19, 850103621$domain:EGF-like 1; incomplete, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103698$domain:EGF-like 7, 850103700$domain:EGF-like 8, 850103702$domain:EGF-like 9, 850103780$domain:Fibrinogen C-terminal, 850103800$domain:Fibronectin type-III 1, 850103801$domain:Fibronectin type-III 10, 850103812$domain:Fibronectin type-III 11, 850103823$domain:Fibronectin type-III 12, 850103835$domain:Fibronectin type-III 13, 850103843$domain:Fibronectin type-III 14, 850103844$domain:Fibronectin type-III 15, 850103845$domain:Fibronectin type-III 16, 850103846$domain:Fibronectin type-III 17, 850103847$domain:Fibronectin type-III 18, 850103848$domain:Fibronectin type-III 19, 850103849$domain:Fibronectin type-III 2, 850103850$domain:Fibronectin type-III 20, 850103851$domain:Fibronectin type-III 21, 850103852$domain:Fibronectin type-III 22, 850103853$domain:Fibronectin type-III 23, 850103854$domain:Fibronectin type-III 24, 850103855$domain:Fibronectin type-III 25, 850103856$domain:Fibronectin type-III 26, 850103857$domain:Fibronectin type-III 27, 850103858$domain:Fibronectin type-III 28, 850103859$domain:Fibronectin type-III 29, 850103860$domain:Fibronectin type-III 3, 850103861$domain:Fibronectin type-III 30, 850103862$domain:Fibronectin type-III 31, 850103863$domain:Fibronectin type-III 32, 850103871$domain:Fibronectin type-III 4, 850103882$domain:Fibronectin type-III 5, 850103893$domain:Fibronectin type-III 6, 850103905$domain:Fibronectin type-III 7, 850103917$domain:Fibronectin type-III 8, 850103930$domain:Fibronectin type-III 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
transmembrane protein 63B,INTERPRO[450003394$IPR003864:Protein of unknown function DUF221]
transmembrane protein 63B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
transmembrane protein 63B,UP_SEQ_FEATURE[850066207$chain:Transmembrane protein 63B, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
tribbles homolog 3 (Drosophila),INTERPRO[450000618$IPR000719:Protein kinase, core, 450015770$IPR017442:Serine/threonine protein kinase-related]
tribbles homolog 3 (Drosophila),SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism, 790001260$protein kinase inhibitor, 790001450$stress response, 790001539$Transcription, 790001543$transcription regulation]
tribbles homolog 3 (Drosophila),UP_SEQ_FEATURE[850066543$chain:Tribbles homolog 3, 850105086$domain:Protein kinase, 850117294$sequence conflict, 850117295$sequence variant]
vestigial like 4 (Drosophila),INTERPRO[450006046$IPR006627:Protein of unknown function TDU]
vestigial like 4 (Drosophila),SMART[760000618$SM00711:TDU]
vestigial like 4 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
vestigial like 4 (Drosophila),UP_SEQ_FEATURE[850064941$chain:Transcription cofactor vestigial-like protein 4, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
zinc finger CCCH-type containing 12D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000498$Endonuclease, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001049$nuclease, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
zinc finger CCCH-type containing 12D,UP_SEQ_FEATURE[850043587$chain:Probable ribonuclease ZC3H12D, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118751$zinc finger region:C3H1-type]
zinc finger protein 181,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 181,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 181,PIR_SUPERFAMILY[630005483$PIRSF005559:zinc finger protein ZFP-36]
zinc finger protein 181,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 181,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 181,UP_SEQ_FEATURE[850101475$chain:Zinc finger protein 181, 850104552$domain:KRAB, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 598,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 598,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
zinc finger protein 598,SMART[760000158$SM00184:RING, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 598,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 598,UP_SEQ_FEATURE[850101781$chain:Zinc finger protein 598, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118655$zinc finger region:C2H2-type, 850118911$zinc finger region:RING-type]
